UP

Pfizer: Our new COVID pill reduces risk of death by 89%

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Pfizer said its COVID-19 pill reduces the risk of hospitalization or death by 89%.

Axar.az reports that the statement came from the US pharmaceutical giant on Friday.

No deaths were reported in patients who received the company's COVID-19 oral antiviral pill PAXLOVID in the overall study population through Day 28, compared to 10 deaths in patients who received a placebo, it said.

The study was based on data from 1,219 adults who were enrolled by Sept. 29 and had a laboratory-confirmed diagnosis of SARS-CoV-2 infection within a five-day period, as well as at least one medical condition associated with an increased risk of developing severe illness from COVID-19, it added.

The company said it will submit the study to the US' Food and Drug Administration (FDA) for emergency use authorization as soon as possible.

The news makes Pfizer the second company in the world to develop a pill against the coronavirus after Merck's oral antiviral treatment drug Molnupiravir, announced on Oct. 1.

Date
2021.11.05 / 17:09
Author
Axar.az
See also

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla